EU approves AbbVie's Boey for short-duration frown line treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. ORCL
2. NVDA
3. SPY
4. USO
5. SRRK
6. DFTX
7. AZN
8. LYNX
9. CGEM
10. SATL

Go back to EU approves AbbVie's Boey for short-duration frown line treatment
AbbVie (NYSE: ABBV) Delayed: 262.08 +4.96 (1.93%)
Previous Close $257.12    52 Week High $68.12 
Open $261.67    52 Week Low $50.71 
Day High $264.65    P/E 56.85 
Day Low $260.10    EPS $4.61 
Volume 1,450,506